Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. (Q41158897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sara Ceccarelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Daniela Gnani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Anna Alisi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Lorenza Putignani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Valerio Nobili

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

A Miccheli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

G Capuani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

F Marini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

A Tomassini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

G Baviera

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

26 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

1118-1125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ijo.2015.40

3 March 2020

exact match

0 references

cites work

Reversing the obesity epidemic in young people: building up the physical activity side of energy balance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 induce different age-related metabolic profiles revealed by 1H-NMR spectroscopy in urine and feces of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Panorganismal gut microbiome-host metabolic crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

HMDB 3.0--The Human Metabolome Database in 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

ANOVA-simultaneous component analysis (ASCA): a new tool for analyzing designed metabolomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Serum metabolic profiles in overweight and obese women with and without metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Metabolic signatures of insulin resistance in 7,098 young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Ribosomal RNA pseudouridines and pseudouridine synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Pseudouridine in RNA: what, where, how, and why

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Oxidative stress parameters in paediatric non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Noninvasive markers of oxidative DNA stress, RNA degradation and protein degradation are differentially correlated with resting metabolic rate and energy intake in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Symbiotic gut microbes modulate human metabolic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Biosynthesis of 2-hydroxyisobutyric acid (2-HIBA) from renewable carbon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Gut microbiota and GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Excessive excretion of beta-alanine and of 3-hydroxypropionic, R- and S-3-aminoisobutyric, R- and S-3-hydroxyisobutyric and S-2-(hydroxymethyl)butyric acids probably due to a defect in the metabolism of the corresponding malonic semialdehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25809828

12 December 2020

inferred from PubMed ID database lookup

Whole-body degradation rates of transfer-, ribosomal-, and messenger ribonucleic acids and resting metabolic rate in 3- to 18-year-old humans

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25809828

12 December 2020

inferred from PubMed ID database lookup

Interrelation between whole-body turnover rates of RNA and protein

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25809828

12 December 2020

inferred from PubMed ID database lookup

A non-targeted metabolomics approach to evaluate the effects of biomass growth and chitosan elicitation on primary and secondary metabolism of Hypericum perforatum in vitro roots

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.40

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/IJO.2015.40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809828%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference